NCT00246025 - A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery. | Biotech Hunter

Enrollment

512

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

June 30, 2007

Conditions

Arthroplasty, Replacement, KneeVenous Thrombosis

Interventions

DRUG

Dabigatran etexilate

Dabigatran etexilate 110 mg capsule, once a day, oral administration

DRUG

Dabigatran etexilate

Dabigatran etexilate 150 mg capsule, once a day, oral administration

DRUG

Dabigatran Etexilate

Dabigatran etexilate 220 mg capsule, once a day, oral administration

DRUG

placebo

matching placebo capsule, once a day, oral administration

Trial Locations (38)

Unknown

1160.50.001 Boehringer Ingelheim Investigational Site, Eniwa, Hokkaido

1160.50.018 Boehringer Ingelheim Investigational Site, Fukuoka, Fukuoka

1160.50.008 Boehringer Ingelheim Investigational Site, Hachioji, Tokyo

1160.50.006 Boehringer Ingelheim Investigational Site, Hirosaki, Aomori

1160.50.026 Boehringer Ingelheim Investigational Site, Hiroshima, Hiroshima

1160.50.011 Boehringer Ingelheim Investigational Site, Iida, Nagano

1160.50.024 Boehringer Ingelheim Investigational Site, Izumisano, Osaka

1160.50.045 Boehringer Ingelheim Investigational Site, Izunokuni,Shizuoka

1160.50.022 Boehringer Ingelheim Investigational Site, Kagoshima, Kagoshima

1160.50.027 Boehringer Ingelheim Investigational Site, Kawasaki, Kanagawa

1160.50.032 Boehringer Ingelheim Investigational Site, Kawasaki, Kanagawa

1160.50.041 Boehringer Ingelheim Investigational Site, Kitakyusyu, Fukuoka

1160.50.039 Boehringer Ingelheim Investigational Site, Koshigaya,Saitama

1160.50.037 Boehringer Ingelheim Investigational Site, Kurume ,Fukuoka

1160.50.038 Boehringer Ingelheim Investigational Site, Kurume ,Fukuoka

1160.50.013 Boehringer Ingelheim Investigational Site, Kyoto, Kyoto

1160.50.036 Boehringer Ingelheim Investigational Site, Matsue, Shimane

1160.50.042 Boehringer Ingelheim Investigational Site, Miyazaki, Miyazaki

1160.50.028 Boehringer Ingelheim Investigational Site, Musashimurayama, Tokyo

1160.50.005 Boehringer Ingelheim Investigational Site, Obihiro, Hokkaido

1160.50.030 Boehringer Ingelheim Investigational Site, Okayama, Okayama

1160.50.021 Boehringer Ingelheim Investigational Site, Omura, Nagasaki

1160.50.014 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1160.50.015 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1160.50.016 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1160.50.033 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1160.50.031 Boehringer Ingelheim Investigational Site, Saga, Saga

1160.50.009 Boehringer Ingelheim Investigational Site, Sagamihara, Kanagawa

1160.50.002 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1160.50.004 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1160.50.020 Boehringer Ingelheim Investigational Site, Sasebo, Nagasaki

1160.50.025 Boehringer Ingelheim Investigational Site, Sasebo, Nagasaki

1160.50.034 Boehringer Ingelheim Investigational Site, Sendai, Miyagi

1160.50.029 Boehringer Ingelheim Investigational Site, Shinjuku-ku,Tokyo

1160.50.043 Boehringer Ingelheim Investigational Site, Shizuoka, Shizuoka

1160.50.044 Boehringer Ingelheim Investigational Site, Sumida-ku, Tokyo

1160.50.023 Boehringer Ingelheim Investigational Site, Tomigusuku, Okinawa

1160.50.040 Boehringer Ingelheim Investigational Site, Tsukuba , Ibaraki